Press Release Archives

10.04.2012

Deciphera Pharmaceuticals Announces Transition to an Oncology Drug Development Company

Read More
08.29.2012

Deciphera Pharmaceuticals Announces Approval of rebastinib patent in Japan

Read More
06.11.2012

Deciphera Pharmacueticals Announces Appointment of Kapil Bhalla, MD to its Scientific Advisory Board

Read More
04.26.2012

Deciphera Pharmaceuticals Announces Appointment of Dr. Patrick O’Connor to its Scientific Advisory Board

Read More
02.01.2012

Deciphera Pharmaceuticals Announces Collaboration Milestone with Eli Lilly and Company

Read More
07.18.2011

Kansas Biosciences Authority Votes in Favor of a $1.6MM Product Development Grant to Deciphera.

Read More
07.06.2011

Deciphera Pharmaceuticals and the University of Kansas Cancer Center team up for clinical study of leukemia drug

Read More
04.18.2011

Deciphera Pharmaceuticals Announces DCC-2036 research for CML published in Cancer Cell.

Read More
01.17.2011

Deciphera Pharmaceuticals Announces Extension of BRAF collaboration and Receipt of Development Milestone from Eli Lilly and Company.

Read More
04.07.2009

Deciphera Pharmaceuticals announces initiation of DCC-2036 Phase 1 Clinical Trial in Refractory CML and All

Read More
10.03.2008

KU to lease out vacant lab space for local expansion by Deciphera Pharmaceuticals

Read More
10.03.2008

Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement

Read More